Cargando…
Belimumab in childhood systemic lupus erythematosus: A review of available data
INTRODUCTION: Childhood systemic lupus erythematosus (cSLE) is a complex multisystem autoimmune disease. In 2019, belimumab was approved for the clinical treatment for cSLE, making it the only biological agent approved for cSLE children aged 5 and older in 60 years. OBJECTIVE: To review emerging evi...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363663/ https://www.ncbi.nlm.nih.gov/pubmed/35967351 http://dx.doi.org/10.3389/fimmu.2022.940416 |